🔎 Trials Near Me

Hjem › Ikke-småcellet lungekreft › Massachusetts › Worcester

Kliniske studier for Ikke-småcellet lungekreft i Worcester, MA

14 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Worcester (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

RekruttererFase 3
  • University of Massachusetts Memorial Medical Center, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06472245

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RekruttererFase 3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

RekruttererFase 3
  • Reliant Medical Group, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06890598

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

RekruttererFase 3
  • Clinical Study Site, Worcester
  • Clinical Study Site, Milford · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

RekruttererFase 2/3
  • Dana-Farber Brigham and Womens Cancer Center at Milford Regional, Milford · 17 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04613596

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2/3
  • UMass Memorial Medical Center - University Campus, Worcester
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2
  • UMass Memorial Medical Center - University Campus, Worcester
18 Minutes · Alle kjønn · Oppdatert 5. mai 2026 · NCT06031688

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Worcester
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Ikke-småcellet lungekreft-studier i andre byer

Andre studier i Worcester

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.